Search research articles
Contact Us
Filters
Showing results (61-70 of 383) with videos related to
Page
of 39
Sort By:
The Journal of Thoracic and Cardiovascular Surgery
|
December 23, 2003
Peer review
Andrew S Wechsler, Pamela W Fried
Clinical Liver Disease
|
June 13, 2019
Controversies in hepatitis C therapy: Reactivation of hepatitis B virus
Sarah R Lieber, Michael W Fried
Antiviral Therapy
|
April 1, 1996
Nucleoside analogues and other investigational modalities for the treatment of chronic hepatitis B
M W Fried, J P Sommadossi
Cell and Tissue Kinetics
|
November 1, 1976
Regeneration of CFUs in the marrow of mice exposed to 300 rads after having recovered from 950 rads
A Kedo, J Barone, W Fried
Perfusion
|
January 1, 1991
Oxygen transfer efficiency of three microporous polypropylene membrane oxygenators
D W Fried, J Bell-Thomson
Hepatology (Baltimore, Md.)
|
February 13, 2018
Parsing the guidelines on guidelines: Balancing sensibility and conflict of interest
Stephen D Zucker, Michael W Fried
Gastroenterology
|
January 27, 2009
Nitazoxanide: beyond parasites toward a novel agent for hepatitis C
Jama M Darling, Michael W Fried
Cancer Research
|
April 1, 1977
Effects of cyclophosphamide and of busulfan on spleen colony-forming units and on hematopoietic stroma
W Fried, A Kedo, J Barone
Hepatology (Baltimore, Md.)
|
March 5, 2013
The FDA, bridging data, and hepatitis C
Michael W Fried, Donald M Jensen
Acta Haematologica
|
January 1, 1983
The Pelger-Huet anomaly: a new familial association with polydactyly and trisomy 13 syndrome
M Berman, W Fried, W Knospe
Page
of 39
Search research articles
Search
Showing results (61-70 of 383) with videos related to
Sort By:
Page
of 39
The Journal of Thoracic and Cardiovascular Surgery
|
December 23, 2003
Peer review
Andrew S Wechsler, Pamela W Fried
Clinical Liver Disease
|
June 13, 2019
Controversies in hepatitis C therapy: Reactivation of hepatitis B virus
Sarah R Lieber, Michael W Fried
Antiviral Therapy
|
April 1, 1996
Nucleoside analogues and other investigational modalities for the treatment of chronic hepatitis B
M W Fried, J P Sommadossi
Cell and Tissue Kinetics
|
November 1, 1976
Regeneration of CFUs in the marrow of mice exposed to 300 rads after having recovered from 950 rads
A Kedo, J Barone, W Fried
Perfusion
|
January 1, 1991
Oxygen transfer efficiency of three microporous polypropylene membrane oxygenators
D W Fried, J Bell-Thomson
Hepatology (Baltimore, Md.)
|
February 13, 2018
Parsing the guidelines on guidelines: Balancing sensibility and conflict of interest
Stephen D Zucker, Michael W Fried
Gastroenterology
|
January 27, 2009
Nitazoxanide: beyond parasites toward a novel agent for hepatitis C
Jama M Darling, Michael W Fried
Cancer Research
|
April 1, 1977
Effects of cyclophosphamide and of busulfan on spleen colony-forming units and on hematopoietic stroma
W Fried, A Kedo, J Barone
Hepatology (Baltimore, Md.)
|
March 5, 2013
The FDA, bridging data, and hepatitis C
Michael W Fried, Donald M Jensen
Acta Haematologica
|
January 1, 1983
The Pelger-Huet anomaly: a new familial association with polydactyly and trisomy 13 syndrome
M Berman, W Fried, W Knospe
Page
of 39